Growing Isosceles Pharmaceuticals team pushes to develop novel, non-opioid products to treat acute pain Isosceles Pharmaceuticals welcomed two new team members – Herbert Neuman, MD, MBA, and Thomas …
Isosceles Pharmaceuticals, Inc. Appoints William D. Humphries as its Chief Executive Officer
Seasoned pharmaceutical executive with more than 30 years of Commercial and Business Strategy experience Isosceles Pharmaceuticals Inc. a biotechnology company dedicated to developing, …